Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 1.000 | |
3c4e | C4E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.619 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.612 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.608 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.603 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.603 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.601 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.600 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.597 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.594 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.594 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.594 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.593 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.592 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.591 | |
3jpv | 1DR | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.591 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.589 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.586 | |
4n6z | 2HW | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.586 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.584 | |
4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.584 | |
3uix | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.583 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.582 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.580 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.580 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.579 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.578 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.576 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.575 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.568 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.566 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.564 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.563 | |
3dcv | 55E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.561 | |
2xiz | XIZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.559 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.558 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.557 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.556 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.555 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.554 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.553 | |
3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.552 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.552 | |
2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.544 | |
2c3i | IYZ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.544 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.544 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.540 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.537 | |
2xiy | XIY | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.537 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.535 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.534 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.532 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.531 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.531 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.529 | |
4wbo | ANW | Rhodopsin kinase | / | 0.528 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.527 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.527 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.527 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.527 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.527 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.524 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.522 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.522 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.521 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.520 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.520 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.520 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.520 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.519 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.519 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.519 | |
2xj2 | 985 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.518 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.518 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.518 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.517 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.516 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.516 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.515 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.514 | |
4hyi | 1AO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.514 | |
5av4 | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.514 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.513 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.513 | |
3c50 | ADP | Rhodopsin kinase | / | 0.512 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.511 | |
3t8o | ATP | Rhodopsin kinase | / | 0.511 | |
4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.509 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.508 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.506 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.506 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
3vf9 | 477 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.506 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.505 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.505 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.505 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.504 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.504 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.503 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.503 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.503 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.503 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.503 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.503 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.502 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.502 | |
3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.502 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.502 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.501 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.501 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.501 | |
5aux | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.501 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.500 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.500 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.499 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.499 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.499 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.499 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.498 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.498 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.497 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.497 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.496 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.495 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.495 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.494 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.494 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.494 | |
4bi0 | Z0W | Dual specificity protein kinase TTK | 2.7.12.1 | 0.494 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
4oth | DRN | Serine/threonine-protein kinase N1 | / | 0.494 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.493 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.493 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.493 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.493 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.493 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.493 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
2e9p | 77A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.492 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.492 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.492 | |
3qf9 | NM8 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.492 | |
4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.492 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.492 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.492 | |
4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.492 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.492 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.491 | |
3l9l | L9L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.491 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.490 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.490 | |
2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.489 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.489 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.489 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.489 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.489 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.489 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.488 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.488 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.488 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.488 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.488 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.488 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.488 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.488 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.488 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.488 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.487 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.487 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.487 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.487 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.487 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.486 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.486 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.486 | |
3qk0 | QK0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.486 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.486 | |
4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.486 | |
5auz | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.486 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.485 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.485 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.485 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.484 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.484 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.484 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.484 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.484 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.484 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.484 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.484 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.483 | |
3c4x | ATP | Rhodopsin kinase | / | 0.483 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.483 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.482 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.482 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.482 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.482 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.482 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.482 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.482 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.482 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.482 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.482 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.481 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.481 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.480 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.480 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.480 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.480 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.479 | |
1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.479 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
3nsz | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.479 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.479 | |
4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.479 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.479 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.479 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.479 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.479 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.479 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
2bkz | SBC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.478 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.478 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.478 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4gw8 | 3RA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.478 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.478 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.478 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.477 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.477 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.477 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.477 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.477 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.477 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.477 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.477 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.477 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.476 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.476 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.476 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.476 | |
2v4l | ABJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.476 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.476 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.476 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.476 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.476 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.476 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.475 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.475 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.475 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.474 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.474 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.474 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.474 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.474 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.474 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.474 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.473 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.473 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.473 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.473 | |
4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.473 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.472 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.472 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.472 | |
3c4w | ATP | Rhodopsin kinase | / | 0.472 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.472 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.472 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.472 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.472 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.472 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.472 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.472 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.472 | |
1fp2 | HMO | Isoflavone-7-O-methyltransferase 8 | 2.1.1.150 | 0.471 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.471 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.471 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.471 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.471 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.470 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.470 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.470 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.470 | |
4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.470 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.470 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.469 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.469 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.469 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.469 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.469 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.469 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.469 | |
1klk | PMD | Dihydrofolate reductase | 1.5.1.3 | 0.468 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.468 | |
2izt | 23D | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.468 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.468 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.468 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.468 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.468 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.468 | |
4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.467 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.467 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.467 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.467 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.466 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.466 | |
4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.466 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
2wmv | ZYV | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.465 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.465 | |
3c4z | ADP | Rhodopsin kinase | / | 0.465 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.465 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.465 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.465 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.465 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.465 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.465 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.464 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.464 | |
4ix6 | ADP | Uncharacterized protein | / | 0.464 | |
5f0a | 1FB | cGMP-dependent protein kinase, putative | / | 0.464 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.463 | |
2euf | LQQ | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.463 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.463 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.463 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.463 | |
4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.462 | |
1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.462 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.462 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.462 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.462 | |
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.462 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.462 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
3vet | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.462 | |
4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.462 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
4kz0 | 1UJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.461 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
3ork | AGS | Serine/threonine protein kinase | / | 0.461 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.461 | |
5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.461 | |
1fpq | SAM | Isoliquiritigenin 2'-O-methyltransferase | / | 0.460 | |
1m2q | MNX | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.460 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.460 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.460 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.460 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.460 | |
4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.459 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.459 | |
1zga | HMK | Isoflavone 4'-O-methyltransferase | / | 0.459 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.459 | |
2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.459 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.459 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.459 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.459 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.459 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.458 | |
3ibe | L64 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.458 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.458 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.458 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.458 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
5auu | LU2 | Death-associated protein kinase 1 | 2.7.11.1 | 0.458 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2bhh | RYU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2oj9 | BMI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.457 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
2vag | V25 | Dual specificity protein kinase CLK1 | 2.7.12.1 | 0.457 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.457 | |
3rps | 4B0 | Casein kinase II subunit alpha | 2.7.11.1 | 0.457 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.457 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.457 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.457 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.456 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.456 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
3jw3 | TOP | Dihydrofolate reductase | / | 0.456 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
3q5i | ANP | Protein kinase, putative | / | 0.456 | |
3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
3vf2 | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.456 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.456 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.455 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.455 | |
2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.455 | |
2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.455 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.455 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.455 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.455 | |
3pre | 3RE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
3vw6 | IM6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.455 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.455 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.455 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.455 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.455 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.454 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.454 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.454 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.454 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.454 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.454 | |
3pvw | QRX | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.454 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.454 | |
2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.453 | |
2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.453 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.453 | |
3q9w | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.453 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4c35 | NU3 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
4h4z | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.453 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.453 | |
4k9y | K9Y | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.453 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.453 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.452 | |
1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.452 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.452 | |
2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.452 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.452 | |
4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
4h3q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.451 | |
2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.451 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.451 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.451 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.451 | |
3gu5 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.451 | |
1q4t | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.450 | |
1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
1x2h | LPA | Lipoate-protein ligase A | 6.3.1.20 | 0.450 | |
2uxi | G50 | HTH-type transcriptional regulator TtgR | / | 0.450 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.450 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
3dpd | 41A | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.450 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.450 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.450 | |
1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
2etk | HFS | Rho-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
2pul | ACP | Methylthioribose kinase | 2.7.1.100 | 0.449 | |
2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.449 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.449 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.449 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.449 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.449 | |
4fa6 | 0TA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
4h4x | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.449 | |
4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.448 | |
3pe2 | E1B | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.448 | |
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 0.448 | |
4j71 | 1JX | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1uyr | D1L | Acetyl-CoA carboxylase | / | 0.447 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
1ydr | IQP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.447 | |
2ivp | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.447 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.447 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.447 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.446 | |
2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.446 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3i81 | EBI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.446 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.446 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.446 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.446 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
1ke9 | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
1u2g | APR | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.445 | |
1v0o | INR | Cell division control protein 2 homolog | 2.7.11.22 | 0.445 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.445 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.445 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.445 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3pvu | QRW | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.445 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4b4o | NDP | Epimerase family protein SDR39U1 | / | 0.445 | |
4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.445 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.445 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.445 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.445 | |
4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.445 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.445 | |
1lhv | NOG | Sex hormone-binding globulin | / | 0.444 | |
1qxl | FR8 | Adenosine deaminase | 3.5.4.4 | 0.444 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.444 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.444 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.444 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.444 | |
2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.444 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.444 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.444 | |
3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.444 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
3q9z | TXQ | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.444 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.444 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
4d4s | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.444 | |
4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.444 | |
4y93 | 746 | Tyrosine-protein kinase | / | 0.444 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
1me8 | RVP | Inosine-5'-monophosphate dehydrogenase | / | 0.443 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.443 | |
2oji | 33A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
2zdu | 446 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.443 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.443 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
4fks | 46K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4j6i | 1JV | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.443 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.443 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.442 | |
2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.442 | |
3pgq | GY3 | Acetyl-CoA carboxylase | / | 0.442 | |
3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.442 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
4ixg | IXG | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.442 | |
2gnf | Y27 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.441 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.441 | |
3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.441 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.441 | |
4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.441 | |
4nm0 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.441 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.441 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
4wq4 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.441 | |
1g3m | PCQ | Estrogen sulfotransferase | 2.8.2.4 | 0.440 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.440 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.440 | |
2etr | Y27 | Rho-associated protein kinase 1 | 2.7.11.1 | 0.440 | |
3c13 | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
3upy | FOM | Oxidoreductase, putative | / | 0.440 | |
3vew | ADP | nebramycin 5' synthase | 6.1.2.2 | 0.440 | |
3vjh | J35 | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.440 |